Clinical and analytical validation of FoundationOne®CDx, a comprehensive genomic profiling assay for solid tumors | PLOS ONE
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision‐Making for Patients with Advanced Solid Tumors - Takeda - 2021 - The Oncologist - Wiley Online Library
Gene therapy - Wikipedia
Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study | PNAS
Clinical and analytical validation of FoundationOne®CDx, a comprehensive genomic profiling assay for solid tumors | PLOS ONE
Automated next-generation profiling of genomic alterations in human cancers | Nature Communications
Compare Our Tests | Foundation Medicine
FoundationOne Liquid CDx | Foundation Medicine
When should we order a next generation sequencing test in a patient with cancer? - eClinicalMedicine
DNA damage repair genes included in FoundationOne CDx NGS panel | Download Scientific Diagram
IJNS | Free Full-Text | Towards Next-Generation Sequencing (NGS)-Based Newborn Screening: A Technical Study to Prepare for the Challenges Ahead
FoundationOne Heme | Foundation Medicine
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome | Journal of Clinical Oncology
Clinical and analytical validation of FoundationOne®CDx, a comprehensive genomic profiling assay for solid tumors | PLOS ONE
FoundationOne® CDx Cancer Genomic Profile Product Overview
PancancerLight 800 gDNA Reference Standard | LinkedIn
Systematic illumination of druggable genes in cancer genomes - ScienceDirect
Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families | npj Breast Cancer
A whole-genome reference panel of 14,393 individuals for East Asian populations accelerates discovery of rare functional variants | Science Advances
The genetic architecture of pediatric cardiomyopathy - ScienceDirect
Half of germline pathogenic and likely pathogenic variants found on panel tests do not fulfil NHS testing criteria | Scientific Reports
AVENIO Tumor Tissue CGP Kit
